JP2024543345A5 - - Google Patents

Info

Publication number
JP2024543345A5
JP2024543345A5 JP2024526836A JP2024526836A JP2024543345A5 JP 2024543345 A5 JP2024543345 A5 JP 2024543345A5 JP 2024526836 A JP2024526836 A JP 2024526836A JP 2024526836 A JP2024526836 A JP 2024526836A JP 2024543345 A5 JP2024543345 A5 JP 2024543345A5
Authority
JP
Japan
Prior art keywords
weeks
week
subject
composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2024526836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543345A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/049969 external-priority patent/WO2023091414A1/en
Publication of JP2024543345A publication Critical patent/JP2024543345A/ja
Publication of JP2024543345A5 publication Critical patent/JP2024543345A5/ja
Withdrawn legal-status Critical Current

Links

JP2024526836A 2021-11-16 2022-11-15 Mds関連貧血及び他の状態を処置するための化合物 Withdrawn JP2024543345A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163280069P 2021-11-16 2021-11-16
US63/280,069 2021-11-16
US202263357240P 2022-06-30 2022-06-30
US63/357,240 2022-06-30
PCT/US2022/049969 WO2023091414A1 (en) 2021-11-16 2022-11-15 Compounds for treating mds-associated anemias and other conditions

Publications (2)

Publication Number Publication Date
JP2024543345A JP2024543345A (ja) 2024-11-21
JP2024543345A5 true JP2024543345A5 (cg-RX-API-DMAC7.html) 2025-11-26

Family

ID=84887868

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526836A Withdrawn JP2024543345A (ja) 2021-11-16 2022-11-15 Mds関連貧血及び他の状態を処置するための化合物

Country Status (11)

Country Link
US (1) US20250108049A1 (cg-RX-API-DMAC7.html)
EP (1) EP4433057A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024543345A (cg-RX-API-DMAC7.html)
KR (1) KR20240107326A (cg-RX-API-DMAC7.html)
AU (1) AU2022390088B2 (cg-RX-API-DMAC7.html)
CA (1) CA3236880A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024001431A1 (cg-RX-API-DMAC7.html)
IL (1) IL312679A (cg-RX-API-DMAC7.html)
MX (1) MX2024005852A (cg-RX-API-DMAC7.html)
TW (1) TW202329935A (cg-RX-API-DMAC7.html)
WO (1) WO2023091414A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024238659A1 (en) * 2023-05-15 2024-11-21 Agios Pharmaceuticals, Inc. Crystalline salts or amorphous forms of 2-((1h-pyrazol-3-yl)methyl)-6-((6-aminopyridin-2-yl)methyl)-4-methyl-4,6-dihydro -5h-thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one
WO2026076363A1 (en) 2024-10-04 2026-04-09 Agios Pharmaceuticals, Inc. Compounds for treating mds-associated anemias and other conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20120693A1 (es) 2009-06-29 2012-07-04 Agios Pharmaceuticals Inc Compuestos heterociclos como moduladores de la piruvato cinasa m2 (pkm2)
MX384883B (es) 2015-06-11 2025-03-14 Agios Pharmaceuticals Inc Métodos para usar activadores de piruvato cinasa.
EP3668513B1 (en) 2017-08-15 2021-11-10 Agios Pharmaceuticals, Inc. Pyruvate kinase activators for use in treating blood disorders
KR102682430B1 (ko) 2017-11-22 2024-07-08 아지오스 파마슈티컬스 아이엔씨. N-(4-(4-(시클로프로필메틸)피페라진-1-카르보닐)페닐)퀴놀린-8-술폰아미드의 결정 형태
JP2022533227A (ja) 2019-05-22 2022-07-21 アジオス ファーマシューティカルズ, インコーポレイテッド N-(4-(4-(シクロプロピルメチル)ピペラジン-1-カルボニル)フェニル)キノリン-8-スルホンアミドの結晶性塩形態

Similar Documents

Publication Publication Date Title
CN1111414C (zh) 镁盐或镁配合物的制药用途
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
JP2022519744A5 (cg-RX-API-DMAC7.html)
JP2022521233A5 (cg-RX-API-DMAC7.html)
JP2024536126A5 (cg-RX-API-DMAC7.html)
JP2018507260A5 (cg-RX-API-DMAC7.html)
CN113842449B (zh) 枸杞糖肽在制备预防和/或治疗肌萎缩侧索硬化的药物中的应用
WO2018214860A1 (zh) 治疗再生障碍性贫血的方法和药物组合物
JP2023553253A5 (cg-RX-API-DMAC7.html)
WO2017148129A1 (zh) 一种用于治疗恶病质的药物组合物及其应用
TWI760306B (zh) 供治療癌症之口服投予紫杉醇及P-gp抑制劑的治療性組合
JP2024545496A5 (cg-RX-API-DMAC7.html)
JPH08512311A (ja) 慢性疲労症候群治療用ヒ素医薬
US20140296149A1 (en) Compositions and Methods for the Treatment of Cardiac Surgery-Associated Acute Kidney Injury with Annexin A1 Peptide
JP7505160B2 (ja) ヒドロキシ尿素を含む炎症反応を阻害するための医薬組成物
JPWO2022265031A5 (cg-RX-API-DMAC7.html)
JP3253878B2 (ja) 鉄キレート化用製剤、その製剤の製法及び地中海貧血症の治療法
JP2025505578A5 (cg-RX-API-DMAC7.html)
CN117224514B (zh) 一种化合物、组合物及其在制备治疗心律失常的药物中的应用
EP3954374A1 (en) Pharmaceutical combination of pimozide and methotrexate and use thereof
US6355682B1 (en) Treatment of acute renal failure by administration of N-acetylcysteine
CN114887063A (zh) Pacsin1在抑制瑞芬太尼诱发的痛觉过敏中的应用
JPS6260368B2 (cg-RX-API-DMAC7.html)
RU2811959C1 (ru) Способ предоперационной коррекции анемии у больных колоректальным раком с метастазами в печень